跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 247,148 条关于
“ANK-203”
全部
247,148
临床试验
232,030
药物
4,245
机构
652
资讯
10,221
7个月前
Ankyra Therapeutics Unveils First-in-Class CD137-Anchored Immunotherapy ANK-203 with Promising Preclinical Anti-Tumor Activity
去年
YolTech's YOLT-203 Shows Promise in Primary Hyperoxaluria Type 1 with Positive Clinical Data
去年
Ankyra Therapeutics Doses First Patient in Visceral Tumor Study with ANK-101
去年
$1.25 Million Boost for Novel Prostate Cancer Drug QED-203 Targeting Advanced Disease
去年
Ankyra Therapeutics Doses First Patient with Visceral Tumor in Phase 1 ANCHOR Trial of ANK-101
去年
Verastem Oncology's RAMP 203 Trial Shows Encouraging Initial Data for Triplet Combination in Advanced KRAS G12C Mutant NSCLC
去年
RESTEM's Restem-L Advances to Phase 2/3 Trial for Idiopathic Inflammatory Myopathy
9个月前
Ankyra Therapeutics Appoints Sailaja Battula as Chief Scientific Officer to Lead Immuno-Oncology Pipeline
2年前
First Patients Dosed in Phase 1 Trial of In Vivo CRISPR Therapy YOLT-203 for Primary Hyperoxaluria Type 1
10个月前
Ankyra Therapeutics Initiates Phase 1b Trial of Anchored IL-12 Immunotherapy Combined with Checkpoint Blockade in Lung Cancer
第 1 页,共 1023 页
上一页
下一页